Ruben Amorim suggested that Marcus Rashford is not putting maximum effort in every day and that kind of attitude simply would ...

SQZ Biotechnologies (NYSE:SQZ – Get Free Report) and Precision BioSciences (NASDAQ:DTIL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast ...

Homozygous familial hypercholesterolaemia affects approximately 30 000 individuals worldwide.1,2 Patients have untreated high ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...

As Trump's backlash against DEI policies gathers pace, what does this show us about the complexity of such programmes?

Rare disease drug maker Pharming Group is calling off the search for a CEO successor to longtime chief Sijmen de Vries after ...

Jupiter Neurosciences JUNS shares decreased by 21.4% to $1.14 during Friday's pre-market session. The market value of their outstanding shares is at $37.7 million. Artiva Biotherapeutics ARTV shares ...

Transactions Senior Resource Group acquires Atria community Senior Resource Group announced it has acquired Atria Mt. Pleasant, a retirement community ...

Arcus Biosciences Inc . (NYSE:RCUS) stock has reached a 52-week low, touching down at $13.48. This latest price movement ...

Psyllium is virtually calorie-free, making it an excellent choice for those aiming to manage their weight while keeping an ...

Arcus Biosciences named former Amgen executive Richard Markus as its chief medical officer. The biopharmaceutical company, which is focused on cancer treatments, said Tuesday that Markus is scheduled ...

Arcus Biosciences (RCUS) announced that Richard Markus, M.D., Ph.D., has been appointed chief medical officer effective January 31, 2025. Dr.